TY - CHAP
T1 - Metabotropic glutamate receptors and cognition
T2 - From underlying plasticity and neuroprotection to cognitive disorders and therapeutic targets
AU - Hoglund, Brandon K.
AU - Carfagno, Vincent
AU - Olive, M. Foster
AU - Leyrer-Jackson, Jonna M.
N1 - Funding Information:
This work was supported by Public Health Service grants F32AA027962 to J.M.L.J., as well as DA043172 and AA025590 to M.F.O.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022
Y1 - 2022
N2 - Metabotropic glutamate (mGlu) receptors are G protein-coupled receptors that play pivotal roles in mediating the activity of neurons and other cell types within the brain, communication between cell types, synaptic plasticity, and gene expression. As such, these receptors play an important role in a number of cognitive processes. In this chapter, we discuss the role of mGlu receptors in various forms of cognition and their underlying physiology, with an emphasis on cognitive dysfunction. Specifically, we highlight evidence that links mGlu physiology to cognitive dysfunction across brain disorders including Parkinson's disease, Alzheimer's disease, Fragile X syndrome, post-traumatic stress disorder, and schizophrenia. We also provide recent evidence demonstrating that mGlu receptors may elicit neuroprotective effects in particular disease states. Lastly, we discuss how mGlu receptors can be targeted utilizing positive and negative allosteric modulators as well as subtype specific agonists and antagonist to restore cognitive function across these disorders.
AB - Metabotropic glutamate (mGlu) receptors are G protein-coupled receptors that play pivotal roles in mediating the activity of neurons and other cell types within the brain, communication between cell types, synaptic plasticity, and gene expression. As such, these receptors play an important role in a number of cognitive processes. In this chapter, we discuss the role of mGlu receptors in various forms of cognition and their underlying physiology, with an emphasis on cognitive dysfunction. Specifically, we highlight evidence that links mGlu physiology to cognitive dysfunction across brain disorders including Parkinson's disease, Alzheimer's disease, Fragile X syndrome, post-traumatic stress disorder, and schizophrenia. We also provide recent evidence demonstrating that mGlu receptors may elicit neuroprotective effects in particular disease states. Lastly, we discuss how mGlu receptors can be targeted utilizing positive and negative allosteric modulators as well as subtype specific agonists and antagonist to restore cognitive function across these disorders.
KW - Cognition
KW - Excitatory transmission
KW - Glutamate
KW - Metabotropic receptor
KW - Plasticity
UR - http://www.scopus.com/inward/record.url?scp=85141462685&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141462685&partnerID=8YFLogxK
U2 - 10.1016/bs.irn.2022.10.004
DO - 10.1016/bs.irn.2022.10.004
M3 - Chapter
AN - SCOPUS:85141462685
T3 - International Review of Neurobiology
BT - International Review of Neurobiology
PB - Academic Press Inc
ER -